RXRX – Recursion Pharmaceuticals, Inc.
Recursion Pharmaceuticals, Inc.RXRX
$9.28Name : Recursion Pharmaceuticals, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $3,625,900,032.00
EPSttm : -1.54
Recursion Pharmaceuticals, Inc.
$9.28
10.34%$1.07Float Short %
21.47
Margin Of Safety %
Put/Call OI Ratio
0.48
EPS Next Q Diff
-0.14
EPS Last/This Y
EPS This/Next Y
-0.1
Price
9.27
Target Price
9
Analyst Recom
2.43
Performance Q
52.13
Relative Volume
1.46
Beta
0.87
Ticker: RXRX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-01-23 | RXRX | 7.52 | 0.30 | 0.18 | 198923 |
| 2025-01-24 | RXRX | 7.33 | 0.30 | 0.11 | 204938 |
| 2025-01-27 | RXRX | 7.05 | 0.30 | 0.23 | 204320 |
| 2025-01-28 | RXRX | 7.42 | 0.31 | 0.12 | 218552 |
| 2025-01-29 | RXRX | 7.15 | 0.29 | 0.44 | 232351 |
| 2025-01-30 | RXRX | 7.71 | 0.30 | 0.13 | 234967 |
| 2025-01-31 | RXRX | 7.26 | 0.29 | 0.20 | 241513 |
| 2025-02-03 | RXRX | 7.23 | 0.34 | 0.23 | 197734 |
| 2025-02-04 | RXRX | 7.61 | 0.34 | 0.36 | 203901 |
| 2025-02-05 | RXRX | 7.92 | 0.35 | 0.25 | 209785 |
| 2025-02-06 | RXRX | 7.26 | 0.36 | 0.27 | 224568 |
| 2025-02-07 | RXRX | 7.5 | 0.35 | 0.20 | 234146 |
| 2025-02-10 | RXRX | 7.66 | 0.34 | 0.17 | 222528 |
| 2025-02-11 | RXRX | 7.66 | 0.34 | 0.35 | 230046 |
| 2025-02-12 | RXRX | 8.34 | 0.34 | 0.27 | 233213 |
| 2025-02-13 | RXRX | 8.51 | 0.35 | 0.26 | 243955 |
| 2025-02-14 | RXRX | 10.53 | 0.34 | 0.33 | 249364 |
| 2025-02-18 | RXRX | 10.72 | 0.44 | 0.34 | 251040 |
| 2025-02-19 | RXRX | 10.89 | 0.44 | 0.45 | 309822 |
| 2025-02-20 | RXRX | 10.34 | 0.49 | 0.42 | 327505 |
| 2025-02-21 | RXRX | 9.3 | 0.48 | 0.57 | 338019 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-01-23 | RXRX | 7.53 | 1.7 | - | -1.54 |
| 2025-01-24 | RXRX | 7.33 | 1.7 | - | -1.54 |
| 2025-01-27 | RXRX | 7.05 | 1.7 | - | -1.54 |
| 2025-01-28 | RXRX | 7.41 | 1.7 | - | -1.54 |
| 2025-01-29 | RXRX | 7.15 | 0.8 | - | -1.54 |
| 2025-01-30 | RXRX | 7.69 | 0.8 | - | -1.54 |
| 2025-01-31 | RXRX | 7.22 | 0.8 | - | -1.54 |
| 2025-02-03 | RXRX | 7.25 | 0.8 | - | -1.54 |
| 2025-02-04 | RXRX | 7.61 | 0.8 | - | -1.54 |
| 2025-02-05 | RXRX | 7.93 | 0.8 | - | -1.54 |
| 2025-02-06 | RXRX | 7.24 | 0.8 | - | -1.54 |
| 2025-02-07 | RXRX | 7.50 | 0.8 | - | -1.54 |
| 2025-02-10 | RXRX | 7.65 | 0.8 | - | -1.54 |
| 2025-02-11 | RXRX | 7.67 | 0.8 | - | -1.54 |
| 2025-02-12 | RXRX | 8.36 | 0.8 | - | -1.54 |
| 2025-02-13 | RXRX | 8.50 | 0.8 | - | -1.54 |
| 2025-02-14 | RXRX | 10.53 | 0.8 | - | -1.54 |
| 2025-02-18 | RXRX | 10.64 | 0.8 | - | -1.54 |
| 2025-02-19 | RXRX | 10.87 | 0.8 | - | -1.54 |
| 2025-02-20 | RXRX | 10.34 | 0.8 | - | -1.54 |
| 2025-02-21 | RXRX | 9.27 | 0.8 | - | -1.54 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-01-23 | RXRX | -0.74 | 2.32 | 22.77 |
| 2025-01-24 | RXRX | -0.74 | 2.32 | 22.77 |
| 2025-01-27 | RXRX | -0.72 | 1.44 | 22.77 |
| 2025-01-28 | RXRX | -0.72 | 1.44 | 20.96 |
| 2025-01-29 | RXRX | -0.72 | 1.44 | 20.96 |
| 2025-01-30 | RXRX | -0.71 | 1.44 | 20.96 |
| 2025-01-31 | RXRX | -0.71 | 1.44 | 20.96 |
| 2025-02-03 | RXRX | -0.71 | -2.17 | 20.96 |
| 2025-02-04 | RXRX | -0.71 | -2.17 | 20.96 |
| 2025-02-05 | RXRX | -0.71 | -2.17 | 20.96 |
| 2025-02-06 | RXRX | -0.71 | -2.17 | 20.96 |
| 2025-02-07 | RXRX | -0.77 | -2.17 | 20.96 |
| 2025-02-10 | RXRX | -0.68 | -3.45 | 21.01 |
| 2025-02-11 | RXRX | -0.67 | -3.45 | 21.01 |
| 2025-02-12 | RXRX | -0.67 | -3.45 | 19.74 |
| 2025-02-13 | RXRX | -0.67 | -3.45 | 19.74 |
| 2025-02-14 | RXRX | -0.67 | -3.45 | 19.74 |
| 2025-02-18 | RXRX | -0.63 | -6.50 | 21.47 |
| 2025-02-19 | RXRX | -0.45 | -6.50 | 21.47 |
| 2025-02-20 | RXRX | -0.45 | -6.50 | 21.47 |
| 2025-02-21 | RXRX | -0.45 | -6.50 | 21.47 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.34
Avg. EPS Est. Current Quarter
-0.41
Avg. EPS Est. Next Quarter
-0.48
Insider Transactions
-0.45
Institutional Transactions
-6.5
Beta
0.87
Average Sales Estimate Current Quarter
18
Average Sales Estimate Next Quarter
12
Fair Value
Quality Score
31
Growth Score
51
Sentiment Score
60
Actual DrawDown %
78.4
Max Drawdown 5-Year %
Target Price
9
P/E
Forward P/E
PEG
P/S
55.63
P/B
5.06
P/Free Cash Flow
EPS
-1.53
Average EPS Est. Cur. Y
-1.54
EPS Next Y. (Est.)
-1.64
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-579.51
Relative Volume
1.46
Return on Equity vs Sector %
-91.2
Return on Equity vs Industry %
-75.6
EPS 1 7Days Diff
-0.1
EPS 1 30Days Diff
0.02
EBIT Estimation
Recursion Pharmaceuticals, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 500
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
stock quote shares RXRX – Recursion Pharmaceuticals, Inc. Stock Price stock today
news today RXRX – Recursion Pharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch RXRX – Recursion Pharmaceuticals, Inc. yahoo finance google finance
stock history RXRX – Recursion Pharmaceuticals, Inc. invest stock market
stock prices RXRX premarket after hours
ticker RXRX fair value insiders trading